3650 results for «498»
3650 results
Hostile access for TAVI procedure
21 May 2025 – From EuroPCR 2025
This session addresses the challenges of hostile vascular access in TAVI procedures. Learn to identify difficult access sites through pre-operative imaging, explore alternative approaches such as axillary access, techniques to overcome iliac access difficulties, and management of peri- and post-operative complications by vascular surgeons.
Best companion's cases on imaging for calcified lesions
20 May 2025 – From EuroPCR 2025
Join this session to explore cutting-edge imaging-guided strategies for treating calcified coronary lesions. Featuring OCT guidance, CT density analysis, and innovative zero-contrast PCI approaches including lithotripsy, this session highlights novel and ultra-low contrast interventions tailored for complex calcified cases and kidney failure patients.
TEER for challenging anatomy: from myth to reality
21 May 2025 – From EuroPCR 2025
Explore advanced TEER techniques for challenging anatomies. This session covers indications, periprocedural steps, state-of-the-art procedural methods, and management of failed surgical tricuspid annuloplasty, with case discussions highlighting practical learnings for complex mitral and tricuspid interventions.
CTO in special clinical scenarios
20 May 2025 – From EuroPCR 2025
This session focuses on the unique challenges of performing CTO interventions in special clinical scenarios, including critical donor artery stenosis, anomalous coronary origins post-TAVI, and complex multivessel disease with limited vascular access. Gain insights into tailored strategies such as retrograde approaches and management after arterial switch...
Treatment and prognostic stratification of ACS patients with cardiogenic shock
21 May 2025 – From EuroPCR 2025
This session focuses on treatment and prognostic stratification in ACS patients complicated by cardiogenic shock. Topics include mechanical CPR device performance, SCAI shock grade dynamics, hemorrhagic event predictors, ECMO-related strategies, and evaluation of BCIS conveyance algorithms for out-of-hospital cardiac arrest.
Intracoronary imaging-guided MINOCA management
20 May 2025 – From EuroPCR 2025
This session addresses the nuanced role of intracoronary imaging in guiding the management of MINOCA patients. Explore interventions including interventional endarterectomy, cutting-balloon PCI for spontaneous coronary artery dissection, strategies for spastic vulnerable plaques, and unusual acute STEMI presentations.
Tough cases, smart imaging
20 May 2025 – From EuroPCR 2025
This session showcases challenging cardiovascular cases where smart imaging techniques guide diagnosis and intervention. Highlights include innovative soft balloon angiography in complex patients, anatomical-physiological ischemic mismatch analysis, IVUS-guided evaluation of rare SVG stenosis, and the power of perspective in imaging interpretation.
When multivessel disease is so complex
21 May 2025 – From EuroPCR 2025
Addressing the complexities of multivessel coronary disease, this session presents challenging cases including double chronic total occlusions and the emerging link between blood lipids and plaque formation. Learn strategic approaches to revascularization in NSTEMI and investigative insights into plaque biology.
A tale of two branches: lessons from complex bifurcation PCI
21 May 2025 – From EuroPCR 2025
Delve into complex bifurcation PCI with detailed case studies illustrating practical approaches to challenging scenarios, including managing stent loss in stented left main bifurcations. Gain valuable lessons from retrograde CTO-PCI and true bifurcation lesions to enhance your procedural strategies.
How to deal with ostial right coronary artery CTOs
20 May 2025 – From EuroPCR 2025
Delve into specialized approaches for managing ostial right coronary artery CTOs. This session discusses scenarios with no clear antegrade path, PCI in high take-off anomalies, retrograde techniques in familial hypercholesterolemia, and complex in-stent CTOs with aortic protrusion.
Challenges in the treatment of patients with left main disease
21 May 2025 – From EuroPCR 2025
Address the challenges in treating patients with left main disease by reviewing bifurcation techniques, intravascular imaging complexities, and intervention dilemmas in renal patients. Cases highlight management of calcified left main disease post-STEMI and nuanced lesion presentations.
Novelties and future developments of sympathetic denervation to control blood pressure
21 May 2025 – From EuroPCR 2025
Discover the latest novelties and future directions in sympathetic denervation for blood pressure control. This session presents preclinical safety data, lesion characteristics, anatomic guidance innovations, multi-organ denervation pilot studies, and breakthrough technologies like the Electroducer sleeve to enhance renal denervation interventions.
Non-antiplatelet drugs interventionalists should be aware of
21 May 2025 – From EuroPCR 2025
Gain essential knowledge on non-antiplatelet drugs relevant to interventional cardiology. Topics include the effects of empagliflozin on oxidative stress, the impact of midazolam on radial spasm during primary PCI, pharmacological cocktails to prevent radial spasm, and hydration strategies in patients with kidney disease during cardiac catheterisation.
Left main stenting techniques
21 May 2025 – From EuroPCR 2025
Examine advanced left main stenting techniques including DK crush and mini-crush strategies for complex bifurcation lesions. This session reviews stent malapposition in trifurcations, novel stent expansion outcomes, bifurcation angle correlations, and clinical results of double kissing crush versus culotte techniques.
Unusual STEMI presentations: coronary embolism
21 May 2025 – From EuroPCR 2025
Investigate unusual STEMI presentations caused by coronary embolism through compelling case studies. Topics include differentiating thrombus from embolism, myocardial infarction after TAVI, paradoxical coronary embolism, septic emboli complications, and complex STEMI scenarios in TAVI patients.
Supraflex for high-risk patients and lesions: from practice to evidence-based medicine proven through FIRE and COMPARE
20 May 2025 – From EuroPCR 2025
Discover the latest evidence on the Supraflex thin-strut sirolimus DES in complex cases—from small vessels and diabetes to STEMI—supported by OCT analysis. This session highlights Supraflex’s performance in high bleeding risk and elderly patients, featuring data from FIRE, COMPARE, EARTH HBR, and Cruz Senior studies. Get...
Symplicity Spyral renal denervation: more insights from clinical practice
21 May 2025 – From EuroPCR 2025
Renal denervation is gaining momentum in the management of hypertension. This EuroPCR 2025 session brings together long-term clinical experience and practical guidance on using the Symplicity Spyral™ system. Learn how to apply the latest European guidelines in daily practice, pick up valuable procedural tips from over...
The future is now: QFR and RMS to optimise coronary artery disease patient management
20 May 2025 – From EuroPCR 2025
See how next-generation technologies are reshaping coronary artery disease treatment in this EuroPCR 2025 session. Learn how QFR is being used to plan PCI and evaluate results, and discover new insights into RMS technology—offering a potential leap beyond traditional drug-eluting stents. From practical case experience to...
TAVI for asymptomatic aortic stenosis after EARLY TAVI - TAVI and coronary artery disease after NOTION-3
21 May 2025 – From EuroPCR 2025
Critically assess the clinical implications of the EARLY TAVI and NOTION-3 trials with a focus on asymptomatic aortic stenosis and concomitant coronary artery disease. This session integrates recent evidence into patient-centered care pathways, offering case-based insights for optimizing timing and management strategies in TAVI patients.
How are we going to treat these sick patients presenting with pulmonary embolism?
21 May 2025 – From EuroPCR 2025
Address the urgent clinical question of how to treat patients presenting with pulmonary embolism across varying risk profiles. This session covers risk stratification and discusses interventional treatment options through detailed case analyses of intermediate and high-risk patients, providing practical guidance for individualized management.
